Company
|
||||||
---|---|---|---|---|---|---|
AbbVie
ABBV
|
NYSE
|
USA
|
Healthcare
|
218.34
$
|
-0.33
%
|
315.06B
$
|
Amgen
AMGN
|
NASDAQ
|
USA
|
Healthcare
|
276.39
$
|
-0.72
%
|
141.01B
$
|
Gilead Sciences
GILD
|
NASDAQ
|
USA
|
Healthcare
|
112.54
$
|
-1.75
%
|
115.92B
$
|
Vertex Pharmaceuticals
VRTX
|
NASDAQ
|
USA
|
Healthcare
|
393.21
$
|
-0.33
%
|
103.86B
$
|
![]()
Genus PLC
GNS
|
LSE
|
UK
|
Healthcare
|
2.62K
£
|
-3.82
%
|
102.57B
£
|
Regeneron Pharmaceuticals
REGN
|
NASDAQ
|
USA
|
Healthcare
|
572.59
$
|
2.25
%
|
81.99B
$
|
PROMOMED
PRMD
|
MOEX
|
Russia
|
Healthcare
|
423.8
₽
|
-0.43
%
|
72.82B
₽
|
![]()
PureTech Health plc
PRTC
|
LSE
|
UK
|
Healthcare
|
113.8
£
|
-1.23
%
|
40.5B
£
|
![]()
argenx NV ADR
ARGX
|
NASDAQ
|
USA
|
Healthcare
|
756.38
$
|
0.06
%
|
40.08B
$
|
Alnylam Pharmaceuticals
ALNY
|
NASDAQ
|
USA
|
Healthcare
|
461.14
$
|
-1.02
%
|
30.04B
$
|
![]()
BioNTech SE
BNTX
|
NASDAQ
|
USA
|
Healthcare
|
96.74
$
|
1.18
%
|
27.37B
$
|
Biodexa Pharmaceticals
BDRX
|
NASDAQ
|
USA
|
Healthcare
|
6.02
$
|
0.17
%
|
27.08B
$
|
Biogen
BIIB
|
NASDAQ
|
USA
|
Healthcare
|
144.86
$
|
-1.06
%
|
22.31B
$
|
Natera
NTRA
|
NASDAQ
|
USA
|
Healthcare
|
168.51
$
|
2.17
%
|
19.74B
$
|
BeiGene, Ltd.
ONC
|
NASDAQ
|
USA
|
Healthcare
|
324.34
$
|
2.44
%
|
19.45B
$
|
4BASEBIO UK SOCIETAS
4BB
|
LSE
|
UK
|
Healthcare
|
840
£
|
-
|
18.72B
£
|
United Therapeutics
UTHR
|
NASDAQ
|
USA
|
Healthcare
|
403.11
$
|
-0.47
%
|
17.11B
$
|
![]()
Avacta Group PLC
AVCT
|
LSE
|
UK
|
Healthcare
|
55
£
|
-1.82
%
|
16.35B
£
|
Moderna
MRNA
|
NASDAQ
|
USA
|
Healthcare
|
23.88
$
|
1.57
%
|
15.97B
$
|
Royalty Pharma Plc
RPRX
|
NASDAQ
|
USA
|
Healthcare
|
35.15
$
|
-3.33
%
|
15.12B
$
|